Analyst Research

Report Title Price
Provider: Reuters Investment Profile
Provider: Sadif Analytics Prime
Provider: Thomson Reuters StreetEvents
Provider: GlobalData

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Biomerieux SA issues FY 2014 financial guidance

Wednesday, 19 Mar 2014 02:00am EDT 

Biomerieux SA:Sees organic sales growth of 3 pct to 5 pct for FY 2014.Sees contributive operating income before non-recurring items of between 220 million euros and 245 million euros for FY 2014. 

Company Quote

-0.29 -0.37%
24 Oct 2014